Skip to main content
Ganesh Benzoplast Ltd. logo

Ganesh Benzoplast Ltd. — Investor Relations & Filings

Ticker · GANESHBE ISIN · INE388A01029 LEI · 335800ADMLACZ4KJML55 BSE.NS Transportation and storage
Open in API
Filings indexed 926 across all filing types
Latest filing 2025-02-06 Regulatory Filings
Country IN India
Listing BSE.NS GANESHBE

About Ganesh Benzoplast Ltd.

https://www.ganeshbenzoplast.com/

Ganesh Benzoplast Ltd. operates as an independent liquid storage tank provider and a manufacturer of specialty chemicals. The company manages a comprehensive network of bulk liquid storage terminals at major ports, offering infrastructure for the handling and storage of liquid chemicals, petroleum products, and edible oils. Its chemical manufacturing division focuses on the production of food preservatives, specifically sodium benzoate, alongside lubricant additives and plasticizers. The organization provides critical logistics support through its storage facilities and supplies chemical components to the food, automotive, and industrial sectors. By integrating port-based storage solutions with chemical production, the company maintains a significant presence in the midstream logistics and specialty chemical supply chains.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-02-06 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a formal letter from Ganesh Benzoplast Limited addressed to stock exchanges (BSE and NSE) informing about an upcoming Board Meeting scheduled for February 12, 2025. The purpose of the meeting is to consider and approve the standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2024. The document references compliance with SEBI Listing Regulations, specifically Regulation 29 (Board Meeting intimation) and Regulation 33 (financial results disclosure). The document is short (1949 characters) and serves as a notification of a board meeting rather than containing any financial results or detailed report itself. Therefore, it is an announcement related to board/management information about a meeting, not the actual financial report or earnings release. Hence, the appropriate classification is Board/Management Information (MANG).
2025-02-06 English
GANESH BENZOPLAST LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve standalone and consolidated ....
Board/Management Information Classification · 95% confidence The document is a formal letter from Ganesh Benzoplast Limited addressed to stock exchanges (BSE and NSE) informing about an upcoming Board Meeting scheduled for February 12, 2025. The purpose of the meeting is to consider and approve the standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2024. The document references compliance with SEBI Listing Regulations, specifically Regulation 29 (Board Meeting intimation) and Regulation 33 (financial results). The document is short (1949 characters) and serves as a notification of a future event (board meeting to approve financial results), not the financial results report itself. Therefore, it is an announcement related to board/management information about a meeting, not the actual financial report or earnings release. Hence, the appropriate classification is Board/Management Information (MANG).
2025-02-06 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) disclosing information pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It details a settlement agreement related to prolonged litigation between the company and another party, including terms of the settlement, payment schedule, and impact on the company's financial position. The document is a regulatory disclosure about a material event (settlement of litigation) rather than a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but provides information required under listing regulations about a significant corporate event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and disclosures that do not fit other specific categories.
2025-01-18 English
Regulation 30 disclosure
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (BSE and NSE) under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, 2015. It informs about a settlement agreement related to prolonged litigation between the company and a counterparty. The document includes details of the litigation, settlement terms, payment schedule, and impact on the company's financial position. There are no financial statements or comprehensive financial analysis present. The document is a regulatory announcement about a material event (litigation settlement) rather than a financial report or earnings release. It fits best under Regulatory Filings (RNS) as it is a compliance disclosure under SEBI regulations and does not constitute an audit report, annual/interim report, or earnings release. The document length (7840 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive regulatory disclosure.
2025-01-18 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialization activities for the quarter ended December 31, 2024. It is addressed to stock exchanges and references compliance with regulatory requirements. The document is short (3268 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is not an announcement of a report but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2025-01-14 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.